Filing Details
- Accession Number:
- 0001593968-21-001243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-06 13:00:00
- Reporting Period:
- 2021-05-05
- Accepted Time:
- 2021-05-06 18:20:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1673772 | Rapt Therapeutics Inc. | RAPT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1635616 | G. Dirk Brockstedt | C/O Rapt Therapeutics, Inc., 561 Eccles Avenue South San Francisco CA 94080 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-05-05 | 2,084 | $21.56 | 19,812 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- Includes 2,084 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on April 30, 2021.